Standard Biotools (LAB) FCF Margin (2010 - 2026)
Standard Biotools (LAB) posted quarterly FCF Margin of 221.87% for Q1 2026, down 4712.0% year-over-year from 4.81% in Q1 2025, and down 2669.85% quarter-over-quarter from 8.01% in Q4 2025.
Standard Biotools (LAB) FCF Margin (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported FCF Margin for 17 consecutive years, with 221.87% the latest figure, recorded in Q1 2026.
- In Q1 2026, FCF Margin fell 4712.0% year-over-year to 221.87%; the TTM figure through Mar 2026 stood at 100.6% (up 3040.0% YoY), while the FY2025 annual figure was 88.12%, up 7150.0% from the prior year.
- FCF Margin retreated to 221.87% in Q1 2026 per LAB's latest filing, from 8.01% in the prior quarter.
- Across five years, FCF Margin topped out at 8.01% in Q4 2025 and bottomed at 221.87% in Q1 2026.
- Historically, FCF Margin has averaged 97.47% across 5 years, with a median of 73.78% in 2022.
- Annual changes were most pronounced in 2023 — FCF Margin soared 12795 bps — and 2024, when it slumped 13340 bps.
- Standard Biotools' FCF Margin stood at 73.78% in 2022, then soared by 46 bps to 40.12% in 2023, then fell by 10 bps to 43.99% in 2024, then jumped by 82 bps to 8.01% in 2025, then plunged by 2670 bps to 221.87% in 2026.
- Business Quant data shows LAB's FCF Margin at 221.87% in Q1 2026, 8.01% in Q4 2025, and 113.31% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.34 Bn | 7.27 Bn | 15.81% |
| 2 | Stryker | 127.40 Bn | 123.93 Bn | 4.50 Bn | 16.07% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 73.24 Bn | 72.71 Bn | 3.85 Bn | 23.50% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.70 Bn | 1.35 Bn | 33.60% |
| 6 | Dexcom | 34.39 Bn | 32.44 Bn | 830.00 Mn | 14.10% |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | 1.28% |
| 8 | Koninklijke Philips | 26.34 Bn | 23.02 Bn | 4.55 Bn | 5.32% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 18.73% |
| 10 | Standard Biotools | 253.41 Mn | -223.31 Mn | 10.54 Mn | -53.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -53.00% |
| Mar 31, 2026 | -221.87% |
| Dec 31, 2025 | -8.01% |
| Sep 30, 2025 | -113.31% |
| Jun 30, 2025 | -72.59% |
| Mar 31, 2025 | -174.75% |
| Dec 31, 2024 | -43.99% |
| Sep 30, 2024 | -148.70% |
| Jun 30, 2024 | -170.14% |
| Mar 31, 2024 | -138.90% |
| Dec 31, 2023 | -40.12% |
| Sep 30, 2023 | -48.56% |
| Jun 30, 2023 | -36.75% |
| Mar 31, 2023 | -37.80% |
| Dec 31, 2022 | -73.78% |
| Sep 30, 2022 | -100.89% |
| Jun 30, 2022 | -164.70% |
| Mar 31, 2022 | -62.10% |
| Sep 30, 2021 | -54.01% |
| Jun 30, 2021 | -60.58% |